|
US4489056A
(en)
*
|
1982-06-30 |
1984-12-18 |
Merck & Co., Inc. |
Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
|
|
US4513143A
(en)
*
|
1982-12-01 |
1985-04-23 |
Sri International |
Preparation of ketene acetals
|
|
US4532335A
(en)
*
|
1983-03-07 |
1985-07-30 |
Sri International |
Preparation of ketene acetals by rearrangement of allyl and substituted allyl acetals
|
|
US4639366A
(en)
*
|
1984-06-06 |
1987-01-27 |
Merck & Co., Inc. |
Polymers containing pendant acid functionalities and labile backbone bonds
|
|
US4549010A
(en)
*
|
1984-06-27 |
1985-10-22 |
Merck & Co., Inc. |
Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal
|
|
US4697575A
(en)
*
|
1984-11-21 |
1987-10-06 |
Henry Ford Hospital |
Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
|
|
US4754745A
(en)
*
|
1984-11-21 |
1988-07-05 |
Horowitz Bruce S |
Conformable sheet material for use in brachytherapy
|
|
US4780319A
(en)
*
|
1985-07-08 |
1988-10-25 |
Merck & Co., Inc. |
Organic acids as catalysts for the erosion of polymers
|
|
US4855132A
(en)
*
|
1986-02-25 |
1989-08-08 |
S R I International |
Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
|
|
US4764364A
(en)
*
|
1986-02-25 |
1988-08-16 |
S R I International |
Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
|
|
US4763642A
(en)
*
|
1986-04-07 |
1988-08-16 |
Horowitz Bruce S |
Intracavitational brachytherapy
|
|
DE3788301D1
(de)
*
|
1986-05-15 |
1994-01-13 |
Hoechst Ag |
Biologisch abbaubare Polymere für Depotzubereitungen mit kontrollierter Wirkstoffabgabe.
|
|
US4713441A
(en)
*
|
1986-08-01 |
1987-12-15 |
Sandoz Pharmaceuticals Corp. |
Polyacetal hydrogels formed from divinyl ethers and polyols
|
|
US4842868A
(en)
*
|
1986-09-26 |
1989-06-27 |
Helwing Robert F |
Covalently bonded active agents with carbonium ion base groups
|
|
DE3700128A1
(de)
*
|
1987-01-03 |
1988-07-14 |
Hoechst Ag |
Biologisch abbaubare poly- (hydroxyalkyl)- aminodicarbonsaeure-derivate, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
|
|
US4913903A
(en)
*
|
1987-02-04 |
1990-04-03 |
Alza Corporation |
Post-surgical applications for bioerodible polymers
|
|
US4957986A
(en)
*
|
1988-08-02 |
1990-09-18 |
E. I. Du Pont De Nemours And Company |
Partially fluorinated polyesters from ketene acetals and fluorine monomers
|
|
US4906714A
(en)
*
|
1988-08-02 |
1990-03-06 |
E. I. Du Pont De Nemours And Company |
Partially fluorinated polyesters from ketene acetals and fluorinated vinyl monomers
|
|
US4957998A
(en)
*
|
1988-08-22 |
1990-09-18 |
Pharmaceutical Delivery Systems, Inc. |
Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages
|
|
US5108755A
(en)
*
|
1989-04-27 |
1992-04-28 |
Sri International |
Biodegradable composites for internal medical use
|
|
US4946931A
(en)
*
|
1989-06-14 |
1990-08-07 |
Pharmaceutical Delivery Systems, Inc. |
Polymers containing carboxy-ortho ester and ortho ester linkages
|
|
US5013821A
(en)
*
|
1989-06-15 |
1991-05-07 |
Pharmaceutical Delivery Systems, Inc. |
Ortho and thio-ortho ester polymer
|
|
US5030457A
(en)
*
|
1989-08-28 |
1991-07-09 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
|
WO1991003510A1
(en)
*
|
1989-08-28 |
1991-03-21 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
|
US5047464A
(en)
*
|
1989-09-20 |
1991-09-10 |
Merck & Co., Inc. |
Bioerodible thermoset elastomers
|
|
US5217712A
(en)
*
|
1989-09-20 |
1993-06-08 |
Merck & Co., Inc. |
Bioerodible thermoset elastomers
|
|
DE4002736A1
(de)
*
|
1990-01-31 |
1991-08-01 |
Hoechst Ag |
Biologisch abbaubare polymere, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
|
|
NZ239370A
(en)
*
|
1990-08-22 |
1994-04-27 |
Merck & Co Inc |
Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
|
|
JPH04120376U
(ja)
*
|
1991-04-16 |
1992-10-28 |
横河電機株式会社 |
リレ−検査回路
|
|
US5211951A
(en)
*
|
1991-07-24 |
1993-05-18 |
Merck & Co., Inc. |
Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
|
|
US5254345A
(en)
*
|
1991-10-11 |
1993-10-19 |
Merck & Co., Inc. |
Poly(orthocarbonate acetal) bioerodible polymers
|
|
US5461140A
(en)
*
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
WO1994025508A1
(en)
*
|
1993-05-03 |
1994-11-10 |
Loctite Corporation |
Polymer dispersed liquid crystals in electron-rich alkene-thiol polymers
|
|
US5401885A
(en)
*
|
1993-06-01 |
1995-03-28 |
Huls America, Inc. |
Method of preparing ortho esters and 1.1-dialkoxycycloalkanes
|
|
US5442033A
(en)
*
|
1993-07-20 |
1995-08-15 |
Ethicon, Inc. |
Liquid copolymers of epsilon-caprolactone and lactide
|
|
ES2109136B1
(es)
*
|
1994-04-22 |
1998-07-01 |
Vita Invest Sa |
Polimeros biodegradables de esqueleto carbonado de acetales de centeno y alcoholes, procedimiento para su obtencion y composicion y utilizacion correspondientes.
|
|
US5811510A
(en)
*
|
1995-04-14 |
1998-09-22 |
General Hospital Corporation |
Biodegradable polyacetal polymers and methods for their formation and use
|
|
FI98136C
(fi)
*
|
1995-09-27 |
1997-04-25 |
Biocon Oy |
Kudosolosuhteissa hajoava materiaali ja menetelmä sen valmistamiseksi
|
|
US5968543A
(en)
*
|
1996-01-05 |
1999-10-19 |
Advanced Polymer Systems, Inc. |
Polymers with controlled physical state and bioerodibility
|
|
US5939453A
(en)
*
|
1998-06-04 |
1999-08-17 |
Advanced Polymer Systems, Inc. |
PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
|
|
KR20010071827A
(ko)
*
|
1998-07-10 |
2001-07-31 |
앤더슨 데릭 제이. |
반점성망막 퇴행에서 신혈관 신생의 예방치료
|
|
AUPQ496500A0
(en)
*
|
2000-01-06 |
2000-02-03 |
University Of Sydney, The |
Kit
|
|
US6613355B2
(en)
*
|
2000-05-11 |
2003-09-02 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
|
US20050042194A1
(en)
|
2000-05-11 |
2005-02-24 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
|
CA2453050A1
(en)
|
2000-09-06 |
2002-03-14 |
A.P. Pharma, Inc. |
Degradable polyacetal polymers
|
|
WO2002092661A1
(en)
*
|
2001-05-11 |
2002-11-21 |
Ap Pharma, Inc. |
Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
|
|
US6590059B2
(en)
*
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
|
US6524606B1
(en)
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
US20040062778A1
(en)
*
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
|
US7354574B2
(en)
*
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US7045589B2
(en)
*
|
2002-11-15 |
2006-05-16 |
A.P. Pharma, Inc. |
Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
|
|
US6863782B2
(en)
*
|
2002-11-15 |
2005-03-08 |
A.P. Pharma, Inc. |
Method of preparing di(ketene acetals)
|
|
WO2004089335A2
(en)
*
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
|
US7083802B2
(en)
*
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US7056591B1
(en)
*
|
2003-07-30 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
|
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7329413B1
(en)
|
2003-11-06 |
2008-02-12 |
Advanced Cardiovascular Systems, Inc. |
Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof
|
|
US9114198B2
(en)
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
|
US7220816B2
(en)
|
2003-12-16 |
2007-05-22 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same
|
|
US7435788B2
(en)
|
2003-12-19 |
2008-10-14 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
|
|
JP2007520496A
(ja)
*
|
2004-02-04 |
2007-07-26 |
レットメッド ピーティーワイ リミテッド |
徐放性ステロイド組成物
|
|
US20050192257A1
(en)
*
|
2004-02-26 |
2005-09-01 |
Peyman Gholam A. |
Predictors for patients at risk for glaucoma from steroid therapy
|
|
JP2007523912A
(ja)
*
|
2004-02-26 |
2007-08-23 |
アドバンスト アキュラー システムズ リミテッド |
眼病変治療用へパリン
|
|
US8685431B2
(en)
|
2004-03-16 |
2014-04-01 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
|
|
US8778014B1
(en)
|
2004-03-31 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for preventing balloon damage to polymer coated stents
|
|
SI1755616T1
(sl)
*
|
2004-04-08 |
2014-04-30 |
Eye Co Pty Ltd. |
Zdravljenje eksudativne retinopatije z mineralkortikoidi
|
|
EP1740168A2
(en)
*
|
2004-04-21 |
2007-01-10 |
Advanced Ocular Systems Limited |
Antiprostaglandins for the treatment of ocular pathologies
|
|
US7820732B2
(en)
|
2004-04-30 |
2010-10-26 |
Advanced Cardiovascular Systems, Inc. |
Methods for modulating thermal and mechanical properties of coatings on implantable devices
|
|
US20050288481A1
(en)
*
|
2004-04-30 |
2005-12-29 |
Desnoyer Jessica R |
Design of poly(ester amides) for the control of agent-release from polymeric compositions
|
|
US20050271700A1
(en)
*
|
2004-06-03 |
2005-12-08 |
Desnoyer Jessica R |
Poly(ester amide) coating composition for implantable devices
|
|
US20050287184A1
(en)
|
2004-06-29 |
2005-12-29 |
Hossainy Syed F A |
Drug-delivery stent formulations for restenosis and vulnerable plaque
|
|
US7350479B2
(en)
*
|
2004-09-10 |
2008-04-01 |
United States Of America As Represented By The Secretary Of The Army |
System and method for controlling growth of aquatic plants utilizing bio-eroding means implanted in triploid grass carp
|
|
US7166680B2
(en)
|
2004-10-06 |
2007-01-23 |
Advanced Cardiovascular Systems, Inc. |
Blends of poly(ester amide) polymers
|
|
US7390497B2
(en)
|
2004-10-29 |
2008-06-24 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) filler blends for modulation of coating properties
|
|
US8609123B2
(en)
|
2004-11-29 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Derivatized poly(ester amide) as a biobeneficial coating
|
|
US20060122152A1
(en)
*
|
2004-12-03 |
2006-06-08 |
Peyman Gholam A |
Heparin for the treatment of ocular pathologies
|
|
US7419504B2
(en)
|
2004-12-27 |
2008-09-02 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) block copolymers
|
|
US8007775B2
(en)
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
|
US7202325B2
(en)
*
|
2005-01-14 |
2007-04-10 |
Advanced Cardiovascular Systems, Inc. |
Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles
|
|
EP1865988A2
(en)
*
|
2005-03-31 |
2007-12-19 |
AP Pharma, Inc. |
Peg-polyacetal diblock and triblock copolymers and pharmaceutical compositions
|
|
AU2006230226A1
(en)
*
|
2005-03-31 |
2006-10-05 |
A.P. Pharma, Inc. |
PEG-poly(ortho ester) graft copolymers and pharmaceutical compositions
|
|
US20070014760A1
(en)
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
|
EP1904056B1
(en)
*
|
2005-07-18 |
2009-04-29 |
Minu, L.L.C. |
Use of a macrolide to restore corneal sensation
|
|
US20070020312A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Desnoyer Jessica R |
Method of fabricating a bioactive agent-releasing implantable medical device
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8377462B2
(en)
*
|
2005-07-29 |
2013-02-19 |
Advanced Cardiovascular Systems, Inc. |
PEA-TEMPO/PEA-BZ coatings for controlled delivery of drug from implantable medical devices
|
|
US7713916B2
(en)
|
2005-09-22 |
2010-05-11 |
Halliburton Energy Services, Inc. |
Orthoester-based surfactants and associated methods
|
|
US20070066493A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Halliburton Energy Services, Inc. |
Orthoester-based surfactants and associated methods
|
|
CN101287739B
(zh)
*
|
2005-10-11 |
2011-05-25 |
富士胶片株式会社 |
含氟螺缩醛化合物及其制备方法
|
|
AU2006318696A1
(en)
|
2005-11-17 |
2007-05-31 |
Zogenix, Inc. |
Delivery of viscous formulations by needle-free injection
|
|
US7910152B2
(en)
*
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
|
SI1854477T1
(sl)
|
2006-03-16 |
2017-01-31 |
Dyax Corp. |
Peptidi, ki inhibirajo plazma kalikrein za uporabo pri zdravljenju očesnih motenj
|
|
US20070264339A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Ap Pharma, Inc. |
Base-stabilized polyorthoester formulations
|
|
US20070264338A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Shah Devang T |
Base-stabilized polyorthoester formulations
|
|
US20070265329A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Devang Shah T |
Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
|
|
US7306040B1
(en)
*
|
2006-06-02 |
2007-12-11 |
Halliburton Energy Services, Inc. |
Stimuli-degradable gels
|
|
US20070281870A1
(en)
*
|
2006-06-02 |
2007-12-06 |
Halliburton Energy Services, Inc. |
Stimuli-degradable gels
|
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
|
US7458953B2
(en)
*
|
2006-06-20 |
2008-12-02 |
Gholam A. Peyman |
Ocular drainage device
|
|
US7875697B2
(en)
|
2006-06-29 |
2011-01-25 |
Medtronic, Inc. |
Poly(orthoester) polymers, and methods of making and using same
|
|
US7771739B2
(en)
*
|
2006-06-30 |
2010-08-10 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices comprising semi-crystalline poly(ester-amide)
|
|
US9028859B2
(en)
|
2006-07-07 |
2015-05-12 |
Advanced Cardiovascular Systems, Inc. |
Phase-separated block copolymer coatings for implantable medical devices
|
|
NZ700275A
(en)
*
|
2006-07-10 |
2016-03-31 |
Delenex Therapeutics Ag |
Scfv antibodies which pass epithelial and/or endothelial layers
|
|
US8030436B2
(en)
*
|
2006-07-13 |
2011-10-04 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester-amide) elastomers and their use with implantable medical devices
|
|
US20090181063A1
(en)
*
|
2006-07-13 |
2009-07-16 |
Michael Huy Ngo |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
|
US7731987B2
(en)
*
|
2006-07-13 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
|
US20080014245A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Stephen Pacetti |
Drug-eluting implantable medical device with free radical scavenger for protecting drugs during sterilization and related method
|
|
US8268347B1
(en)
|
2006-10-24 |
2012-09-18 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
|
US8632809B2
(en)
|
2006-11-09 |
2014-01-21 |
Alcon Research, Ltd. |
Water insoluble polymer matrix for drug delivery
|
|
US20080114076A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Alcon Manufacturing Ltd. |
Punctal plug comprising a water-insoluble polymeric matrix
|
|
US20080175882A1
(en)
*
|
2007-01-23 |
2008-07-24 |
Trollsas Mikael O |
Polymers of aliphatic thioester
|
|
US8252361B2
(en)
*
|
2007-06-05 |
2012-08-28 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices for local and regional treatment
|
|
US20080306584A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Pamela Kramer-Brown |
Implantable medical devices for local and regional treatment
|
|
US9737638B2
(en)
*
|
2007-06-20 |
2017-08-22 |
Abbott Cardiovascular Systems, Inc. |
Polyester amide copolymers having free carboxylic acid pendant groups
|
|
US7927621B2
(en)
*
|
2007-06-25 |
2011-04-19 |
Abbott Cardiovascular Systems Inc. |
Thioester-ester-amide copolymers
|
|
US8956642B2
(en)
|
2008-04-18 |
2015-02-17 |
Medtronic, Inc. |
Bupivacaine formulation in a polyorthoester carrier
|
|
US8475823B2
(en)
|
2008-04-18 |
2013-07-02 |
Medtronic, Inc. |
Baclofen formulation in a polyorthoester carrier
|
|
EP2756756B1
(en)
|
2008-04-28 |
2016-01-06 |
Zogenix, Inc. |
Novel formulations for treatment of migraine
|
|
US8889172B1
(en)
|
2008-04-30 |
2014-11-18 |
Abbott Cardiovascular Systems Inc. |
Amorphous or semi-crystalline poly(ester amide) polymer with a high glass transition temperature
|
|
US20110201869A1
(en)
*
|
2008-05-07 |
2011-08-18 |
Obj Limited |
Method and apparatus for enhanced transdermal diffusion
|
|
US8765162B2
(en)
*
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
|
AU2009270695A1
(en)
|
2008-07-17 |
2010-01-21 |
Ap Pharma |
Methods for enhancing the stability of polyorthoesters and their formulations
|
|
US20100047319A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Michael Huy Ngo |
Biodegradable Poly(Ester-Amide) And Poly(Amide) Coatings For Implantable Medical Devices With Enhanced Bioabsorption Times
|
|
MX2011006265A
(es)
*
|
2008-12-11 |
2012-06-28 |
A P Pharma Inc |
Metodos para mejorar la estabilidad de poliortoesteres y sus formulaciones.
|
|
WO2011046515A1
(en)
|
2009-10-14 |
2011-04-21 |
Nanyang Technological University |
Antiproliferative agent
|
|
EP2343046A1
(en)
|
2010-01-08 |
2011-07-13 |
Nirvana's Tree House B.V. |
Functionalised triblock copolymers and compositions containing such polymers
|
|
US9452037B2
(en)
|
2010-05-25 |
2016-09-27 |
International Scientific Pty Ltd |
Delivery of oral care products
|
|
JP6046609B2
(ja)
|
2010-06-17 |
2016-12-21 |
インターナショナル・サイエンティフィック・プロプライエタリー・リミテッド |
皮膚ケア製品の送達
|
|
US9233238B2
(en)
|
2011-02-23 |
2016-01-12 |
Ams Research Corporation |
Drug releasing pelvic treatment system and method
|
|
US9949811B2
(en)
|
2011-02-23 |
2018-04-24 |
Boston Scientific Scimed, Inc. |
Pelvic implant and therapeutic agent system and method
|
|
EP4026543B1
(en)
|
2011-11-18 |
2024-08-07 |
Regeneron Pharmaceuticals, Inc. |
Polymer coated protein microparticles for extended release formulations for use in the vitreous of the eye for treating vascular eye disorders
|
|
US9849180B2
(en)
|
2014-09-15 |
2017-12-26 |
Hui Rong Shen |
Long-acting semi-solid lipid formulations
|
|
US10220093B2
(en)
|
2013-02-28 |
2019-03-05 |
Mira Pharma Corporation |
Long-acting semi-solid lipid formulations
|
|
US9592227B2
(en)
|
2013-03-15 |
2017-03-14 |
Heron Therapeutics, Inc. |
Compositions of a polyorthoester and an aprotic solvent
|
|
WO2018048460A1
(en)
|
2014-04-21 |
2018-03-15 |
Heron Therapeutics, Inc. |
A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
|
|
US9801945B2
(en)
|
2014-04-21 |
2017-10-31 |
Heron Therapeutics, Inc. |
Long-acting polymeric delivery systems
|
|
US10980886B2
(en)
|
2014-04-21 |
2021-04-20 |
Heron Therapeutics, Inc. |
Compositions of a polyorthoester and an organic acid excipient
|
|
HRP20211612T1
(hr)
|
2014-04-21 |
2022-02-04 |
Heron Therapeutics, Inc. |
Polimerni sustavi za isporuku s dugim djelovanjem
|
|
EP3154552B1
(en)
|
2014-06-11 |
2021-03-24 |
International Scientific Pty Ltd |
Device and method to treat or prevent joint degeneration
|
|
HK1258050A1
(zh)
|
2015-10-23 |
2019-11-01 |
Lyndra Therapeutics, Inc. |
用於治疗剂缓释的胃驻留系统及其使用方法
|
|
WO2017100367A1
(en)
|
2015-12-08 |
2017-06-15 |
Lyndra, Inc. |
Geometric configurations for gastric residence systems
|
|
EP3389636B1
(en)
|
2015-12-16 |
2022-07-20 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods of manufacturing protein microparticles
|
|
AU2017268840B2
(en)
|
2016-05-27 |
2022-02-10 |
Lyndra Therapeutics, Inc. |
Materials architecture for gastric residence systems
|
|
WO2018064630A1
(en)
|
2016-09-30 |
2018-04-05 |
Lyndra, Inc. |
Gastric residence systems for sustained delivery of adamantane-class drugs
|
|
TWI778052B
(zh)
|
2017-04-24 |
2022-09-21 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
|
CA3066658A1
(en)
|
2017-06-09 |
2018-12-13 |
Lyndra, Inc. |
Gastric residence systems with release rate-modulating films
|
|
MX2019015321A
(es)
|
2017-06-16 |
2020-07-20 |
Avery Therapeutics Inc |
Composiciones tridimensionales de tejido y métodos de uso.
|
|
CN111511338B
(zh)
|
2017-09-20 |
2022-11-29 |
林德拉治疗公司 |
胃驻留系统的封装
|
|
US10561606B2
(en)
|
2017-12-06 |
2020-02-18 |
Mira Pharma Corporation |
Injectable long-acting local anesthetic semi-solid gel formulations
|
|
US11426418B2
(en)
|
2017-12-06 |
2022-08-30 |
Mira Pharma Corporation |
Injectable long-acting semi-solid gel formulations
|
|
EP3829719B1
(en)
|
2018-07-27 |
2025-04-02 |
Cocrystal Pharma, Inc. |
Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication
|
|
TWI844564B
(zh)
|
2018-09-10 |
2024-06-11 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
|
AU2019361038B2
(en)
|
2018-10-17 |
2025-07-03 |
Cocrystal Pharma, Inc. |
Combinations of inhibitors of influenza virus replication
|
|
EP3887355A1
(en)
|
2018-11-26 |
2021-10-06 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
|
AU2020394428B2
(en)
|
2019-11-25 |
2025-11-20 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous emulsions
|
|
WO2021146215A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
|
CN115698035A
(zh)
|
2020-04-10 |
2023-02-03 |
共晶制药公司 |
诺如病毒及冠状病毒复制的抑制剂
|
|
KR20230002571A
(ko)
|
2020-04-14 |
2023-01-05 |
더 리전츠 오브 더 유니버시티 오브 캘리포니아 |
큰 서열 범-코로나바이러스 백신 조성물
|
|
MX2023006077A
(es)
|
2020-11-25 |
2023-06-06 |
Regeneron Pharma |
Formulaciones de liberacion sostenida mediante emulsificacion por membrana no acuosa.
|
|
KR20230145053A
(ko)
|
2021-01-12 |
2023-10-17 |
듀렉트 코퍼레이션 |
지속 방출 약물 전달 시스템 및 관련 방법
|
|
US20240398757A1
(en)
|
2021-08-03 |
2024-12-05 |
Cocrystal Pharma, Inc. |
Inhibitors for coronaviruses
|
|
TW202446396A
(zh)
|
2023-04-12 |
2024-12-01 |
美商百年治療公司 |
用於己酮糖激酶抑制之雙取代的嘧啶化合物
|
|
WO2024249612A1
(en)
|
2023-05-31 |
2024-12-05 |
Centennial Therapeutics, Llc |
Bicyclic compounds for ketohexokinase inhibition
|
|
WO2025175208A1
(en)
|
2024-02-16 |
2025-08-21 |
The Regents Of The University Of California |
Intra-vascular drug delivery device and method for focal drug delivery by vascular perfusion
|